These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 29589201

  • 1. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease.
    Mariucci G, Pagiotti R, Galli F, Romani L, Conte C.
    J Mol Neurosci; 2018 Apr; 64(4):611-618. PubMed ID: 29589201
    [Abstract] [Full Text] [Related]

  • 2. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
    Yeo S, Sung B, Hong YM, van den Noort M, Bosch P, Lee SH, Song J, Park SK, Lim S.
    Gene; 2018 Jun 30; 661():189-195. PubMed ID: 29604467
    [Abstract] [Full Text] [Related]

  • 3. Phosphorylated α-Synuclein Accumulations and Lewy Body-like Pathology Distributed in Parkinson's Disease-Related Brain Areas of Aged Rhesus Monkeys Treated with MPTP.
    Huang B, Wu S, Wang Z, Ge L, Rizak JD, Wu J, Li J, Xu L, Lv L, Yin Y, Hu X, Li H.
    Neuroscience; 2018 May 21; 379():302-315. PubMed ID: 29592843
    [Abstract] [Full Text] [Related]

  • 4. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
    Shao QH, Chen Y, Li FF, Wang S, Zhang XL, Yuan YH, Chen NH.
    Acta Pharmacol Sin; 2019 Dec 21; 40(12):1503-1512. PubMed ID: 31388087
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM, Ardah MT, Al Shamsi M, Kitada T, Haque ME.
    Neurotoxicology; 2021 May 21; 84():41-52. PubMed ID: 33549656
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N, Bhurtel S, Shadfar S, Srivastav S, Neupane S, Ojha U, Jeong GS, Choi DY.
    Neuropharmacology; 2017 Oct 21; 125():396-407. PubMed ID: 28807678
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
    Komnig D, Dagli TC, Habib P, Zeyen T, Schulz JB, Falkenburger BH.
    J Neurochem; 2018 Dec 21; 147(5):678-691. PubMed ID: 30152864
    [Abstract] [Full Text] [Related]

  • 16. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
    Huang HJ, Wang YT, Lin HC, Lee YH, Lin AM.
    Mol Neurobiol; 2018 Jan 21; 55(1):138-144. PubMed ID: 28822080
    [Abstract] [Full Text] [Related]

  • 17. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
    Rekha KR, Selvakumar GP, Santha K, Inmozhi Sivakamasundari R.
    Biochem Biophys Res Commun; 2013 Nov 01; 440(4):664-70. PubMed ID: 24103762
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice.
    Matsuo K, Cheng A, Yabuki Y, Takahata I, Miyachi H, Fukunaga K.
    Neuropharmacology; 2019 May 15; 150():164-174. PubMed ID: 30930168
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.